Advertisement

Erythroblastosis Fetalis and Hydrops Fetalis

Keywords

Hydatidiform Mole Hemolytic Disease Fetal Hydrops Fetal Anemia Mesoblastic Nephroma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adzick, N.S., Crombleholme, T.M., Morgan, M.A. and Quinn, T. M.: A rapidly growing fetal teratoma. Lancet 349:538, 1997.PubMedGoogle Scholar
  2. Alenghat, E. and Esterly, J.R.: Intravascular hematopoiesis in chorionic villi. Amer. J. Clin. Pathol. 79:225–227, 1983.Google Scholar
  3. Anand, A., Gray, E.S., Brown, T., Clewley, J.P. and Cohen, B.J.: Human parvovirus infection in pregnancy and hydrops fetalis. NEJM 316:183–186, 1987.PubMedGoogle Scholar
  4. Anandakumar, C., Biswas, A., Chew, S.S.L., Chia, D., Wong, Y. C. and Ratnam, S.S.: Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block. Obstet. Gynecol. 87:835–837, 1996.PubMedGoogle Scholar
  5. Anders, D., Kindermann, G. and Pfeifer, U.: Metastasizing fetal neuroblastoma with involvement of the placenta simulating fetal erythroblastosis. J Pediatr. 82:50–53, 1973.PubMedGoogle Scholar
  6. Anderson, L.J. and Török, T.J.: Human parvovirus B 19. NEJM 321:536–538, 1989.PubMedGoogle Scholar
  7. Anderson, L.J. and Young, N.S.: Human Parvovirus B19. Monographs in Virology, Karger, Basel, 1997.Google Scholar
  8. Anderson, M.J. and Pattison, J.R.: The human parvoviruses: Brief review. Arch. Virol. 82:137–148, 1984.PubMedGoogle Scholar
  9. Anderson, M.J., Khousam, M.N., Maxwell, D.J., Gould, S.J., Happerfield, L.C. and Smith, W.J.: Human parvovirus B19 and hydrops fetalis. Lancet i:535, 1988.Google Scholar
  10. Appelman, Z., Blumberg, B.D., Golabi, M. and Golbus, M.S.: Nonimmune hydrops fetalis may be associated with an elevated delta OD450 in the amniotic fluid. Obstet. Gynecol. 71:1005–1008, 1988.PubMedGoogle Scholar
  11. Aslam, P.A., Korones, S.B., Richardson, R.L. and Pate, J.W.: Congenital cystic adenomatoid malformation with anasarca. JAMA 212:622–624, 1970.PubMedGoogle Scholar
  12. Baergen, R.N., Kelly, T., McGinnis, M.J., Jones, O.W. and Benirschke, K.: Complete hydatidiform mole with coexisting embryo. Human Pathol. 27:731–734, 1996.Google Scholar
  13. Barentsen, R.: Sacrococcygeal teratoom en hydramnion. Nederl. Tidschr. Geneesk. 119:1168–1169, 1975.Google Scholar
  14. Barton, J.R., Thorpe, E.M., Shaver, D.C., Hager, W.D. and Sibai, B.M.: Nonimmune hydrops fetalis associated with maternal infection with syphilis. Amer. J. Obstet. Gynecol. 167:56–58, 1992.Google Scholar
  15. Bawle, E.V. and Black, V.: Nonimmune hydrops fetalis in Noonan’s syndrome. Amer. J. Dis. Childr. 140:758–760, 1986.Google Scholar
  16. Becker, V. und Bleyl, U.: Placentarzotte bei Schwangerschaftstoxikose und fetaler Erythroblastose im fluorescenzmikroskopischen Bilde. Virchows Arch. Pathol. Anat. 334:516–527, 1961.Google Scholar
  17. Beischer, N.A., Holsman, M. and Kitchen, W.H.: Relation of various forms of anemia to placental weight. Amer. J. Obstet. Gynecol. 101:801–809, 1968.Google Scholar
  18. Beischer, N.A., Pepperell, R.J. and Barrie, J.U.: Twin pregnancy and erythroblastosis. Obstetr. Gynecol. 34:22–29, 1969.Google Scholar
  19. Benacerraf, B.R. and Frigoletto, F.D.: In utero treatment of a fetus with diaphragmatic hernia complicated by hydrops. Amer. J. Obstet. Gynecol. 155:817–818, 1986.Google Scholar
  20. Benachi, A., Garritsen, H.S.P., Howard, C.M., Bennett, P. and Fisk, N.M.: Absence of expression of RhD by human trophoblast cells. Amer. J. Obstet. Gynecol. 178:294–299, 1998.Google Scholar
  21. Ben-Ami, M., Shalev, E., Romano, S. and Zuckerman, H.: Midtrimester diagnosis of endocardial fibroelastosis and atrial septal defect: A case report. Amer. J. Obstet. Gynecol. 155:662–663, 1986.Google Scholar
  22. Benirschke, K., Swartz, W.H., Leopold, G. and Sahn, D.: Hydrops due to myocarditis in a fetus. Amer. J. Cardiovasc. Pathol. 1:131–133, 1986.Google Scholar
  23. Berkowitz, R.L., Chitkara, U., Goldberg, J.D., Wilkins, I., Chervenak, F.A. and Lynch, L.: Intrauterine intravascular transfusions for severe red blood cell isoimmunization: Ultrasound-guided percutaneous approach. Amer. J. Obstetr. Gynecol. 155:574–581, 1986.Google Scholar
  24. Bernstein, I.M. and Capeless, E.L.: Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection. Obstet. Gynecol. 74:456–457, 1989.PubMedGoogle Scholar
  25. Birkenfeld, A., Mordel, N. and Okon, E.: Direct demonstration of iron in a term placenta in a case of b-thalassemia. Amer. J. Obstet. Gynecol. 160:562–563, 1989.Google Scholar
  26. Birner, W.F.: Neuroblastoma as a cause of antenatal death. Amer. J. Obstet. Gynecol. 82:1388–1391, 1961.Google Scholar
  27. Bock, B., Riess, R., Wünsch, P.H. und Feige, A.: Pränatale Diagnostik eines Steißbeinteratoms mit Hydrops fetalis und Plazentahypertrophie—Konsequenzen für den weiteren Schwangerschaftsverlauf. Geburtsh. Frauenheilk. 50:647–649, 1990.PubMedGoogle Scholar
  28. Bond, P.R., Caul, E.O., Usher, J., Cohen, B.J., Clewley, J.P. and Field, A.M.: Intrauterine infection with human parvovirus. Lancet i:448–449, 1986.Google Scholar
  29. Bouissou, H., Kanoun, T., Bierme, S. et Bierme, R.: Foie et placenta au cours de la maladie hémolytique par iso-immunisation Rh. (Étude histologique et déductions). Pathol. Biol. 17:109–120, 1969.PubMedGoogle Scholar
  30. Bowman, J.M., Lewis, M. and de Sa, D.J.: Hydrops fetalis caused by massive maternofetal transplacental hemorrhage. J. Pediatr. 104:769–772, 1984.PubMedGoogle Scholar
  31. Bridge, J.A., McManus, B.M., Remmenga, J. and Cuppage, F.P.: Complete heart block in the 18p-syndrome. Congenital calcifi cation of the atrioventricular node. Arch. Pathol. Lab. Med. 113:539–541, 1989.PubMedGoogle Scholar
  32. Briner, J., Hassam, S., Girsberger, M. and Tratschin, J.D.: Demonstration of parvovirus infection in human fetuses and infants by in situ hybridization. Pediatr. Pathol. 7:479–480, 1987.Google Scholar
  33. Brinson, R.A. and Goldsmith, J.P.: Nonimmune hydrops fetalis associated with intrauterine intussusception. J. Perinatol. 8:225–227, 1988.PubMedGoogle Scholar
  34. Broderick, K., Oyer, R. and Chatwani, A.: Neu-Laxova syndrome: A case report. Amer. J. Obstet. Gynecol. 158:574–575, 1988.Google Scholar
  35. Bromley, B., Frigoletto, F.D., Estroff, J.A. and Benacerraf, B.R.: The natural history of oligohydramnios/polyhydramnios sequence in monochorionic diamniotic twins. Ultrasound Obstet. Gynecol. 2:317–320, 1992.PubMedGoogle Scholar
  36. Brown, K.E., Green, S.W., de Mayolo, J.A., Bellanti, J.A., Smith, S.D., Smith, T.J. and Young, N.S.: Congenital anaemia after transplacental B19 parvovirus infection. Lancet 343:895–896, 1994.PubMedGoogle Scholar
  37. Brown, T., Anand, A., Ritschie, L.D., Clewley, J.P. and Reid, T.M.S.: Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034, 1984.Google Scholar
  38. Burger, K.: Mit Hydrops foetus et placentae einhergehende Luteinzysten. Zbl. Gynäkol. 69:533–536, 1947.Google Scholar
  39. Burstein, R.H. and Blumenthal, H.T.: Vascular lesions of the placenta of possible immunogenic origin in erythroblastosis fetalis. Amer. J. Obstetr. Gynecol. 83:1062–1068, 1962.Google Scholar
  40. Burton, P.A. and Caul, E.O.: Fetal cell tropism of human parvovirus B 19. Lancet i:767, 1988.Google Scholar
  41. Busch, W. und Vogel, M.: Die Plazenta beim “Morbus haemolyticus neonatorum”. Z. Geburtsh. Perinatol. 176:17–28, 1972.Google Scholar
  42. Cardwell, M.S.: Successful treatment of hydrops fetalis caused by fetomaternal hemorrhage: A case report. Amer. J. Obstet. Gynecol. 158:131–132, 1988.Google Scholar
  43. Carles, D., Serville, F., Dubecq, J.-P., Alberti, E.M., Horowitz, J. and Weichwold, W.: Idiopathic arterial calcification in a stillborn complicated by pleural hemorrhage and hydrops fetalis. Arch. Pathol. Lab. Med. 116:293–295, 1992.PubMedGoogle Scholar
  44. Carr, S., Rubin, L., Dixon, D., Star, J. and Dailey, J.: Intrauterine therapy for homozygous a-thalassemia. Obstet. Gynecol. 85:876–879, 1995.PubMedGoogle Scholar
  45. Carrington, D., Gilmore, D.H., Whittle, M.J., Aitken, D., Gibson, A.A.M., Patrick, W.J.A., Brown, T., Caul, E.O., Field, A.M., Clewley, J.P. and Cohen, B.J.: Maternal serum α-fetoprotein—a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet i:433–435, 1987.Google Scholar
  46. Carter, B.S., DiGiacomo, J.E., Balderston, S.M., Wiggins, J.W. and Merenstein, G.B.: Disproportionate septal hypertrophy associated with erythroblastosis. Amer. J. Dis. Child. 144: 1225–1228, 1990.PubMedGoogle Scholar
  47. Chang, J.C. and Kan, Y.W.: Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet ii:1127–1129, 1981.Google Scholar
  48. Chen, F.E., Ooi, C., Ha, S.Y., Cheung, B.M.Y., Todd, D., Liang, R., Chan, T.K. and Chan, V.: Genetic and clinical features of hemoglobin H disease in Chinese patients. NEJM 343:544–550, 2000.PubMedGoogle Scholar
  49. Christie, R.W.: Lutein cysts of ovaries associated with erythroblastotic hydrops fetalis. Assay of gonadotropin in serum of Rh-sensitized women in later stages of pregnancy. Amer. J. Clin. Pathol. 36:518–523, 1961.Google Scholar
  50. Clark, S.L., Vitale, D.J., Minton, S.D., Stoddard, R.A. and Sabey, P.L.: Successful fetal therapy for cystic adenomatoid malformation associated with second-trimester hydrops. Amer. J. Obstet. Gynecol. 157:294–295, 1987.Google Scholar
  51. Copel, J.A., Buyon, J.P. and Kleinman, C.S.: Successful in utero therapy of fetal heart block. Amer. J. Obstet. Gynecol. 173:1384–1390, 1995.Google Scholar
  52. Cox, P.M., Brueton, L.A., Murphy, K.W., Worthington, V.C., Bjelorglic, P., Lazda, E.J., Sabire, N.J. and Sewry, C.A.: Early-onset fetal hydrops and muscle degeneration in siblings due to a novel variant of type IV glycogenosis. Amer. J. Med. Genet. 86:187–193, 1999.Google Scholar
  53. Cukierski, M.A., Tarantal, A.F. and Hendrickx, A.G.: A case of nonimmune hydrops fetalis with a rare cardiac anomaly in a rhesus monkey. J. Med. Primatol. 15:227–234, 1986.PubMedGoogle Scholar
  54. Cumming, D.C.: Recurrent nonimmune hydrops fetalis. Obstet. Gynecol. 54:124–126, 1979.PubMedGoogle Scholar
  55. Curry, C.J.R., Chopra, D. and Finer, N.N.: Hydrops and pleural effusions in congenital myotonic dystrophy. J. Pediatr. 113:555–557, 1988.PubMedGoogle Scholar
  56. Davis, C.L.: Diagnosis and management of nonimmune hydrops fetalis. J. Reprod. Med. 27:594–600, 1982.PubMedGoogle Scholar
  57. De Krijger, R.R., van Elsacker-Niele, A.M.W., Mulder-Stapel, A., Salimans, M.M.M., Dreef, E., Weiland, H.T., van Krieken, J.H.J.M. and Vermeij-Keers, C.: Detection of parvovirus B 19 infection in first and second trimester fetal loss. Pediatr. Pathol. Lab. Med. 18:23–34, 1998.PubMedGoogle Scholar
  58. DeLia, J.E. and Emery, M.G.: Digoxin therapy in the fetus. Amer. J. Dis. Childr. 140:974–975, 1986.Google Scholar
  59. Dorman, S.L. and Cardwell, M.S.: Ballantyne syndrome caused by a large placental chorioangioma. Amer. J. Obstet. Gynecol. 173:1632–1633, 1995.Google Scholar
  60. Doss, B.J., Vicari, J., Jacques, S.M. and Qureshi, F.: Placental involvement in congenital hepatoblastoma. Pediat. Development. Pathol. 1:538–542, 1998.Google Scholar
  61. Driscoll, S.G. and Steinke, J.: Pancreatic insulin content in severe erythroblastosis fetalis. Pediatrics 39:449–450, 1967.Google Scholar
  62. Drogendijk, A.C.: The pathogenesis of foetal hydrops. Gynaecologia 156:129–139, 1963.PubMedGoogle Scholar
  63. Drut, R.M. and Drut, R.: Nonimmune fetal hydrops and placenomegaly: Diagnosis of familial Wiedemann-Beckwith syndrome with trisomy 11p15 using FISH. Amer. J. Med. Genet. 62:145–149, 1996.Google Scholar
  64. Drut, R., Mortera, M. and Drut, R.M.: Yolk sac tumor of the placenta in Wiedemann-Beckwith syndrome. Pediat. Development. Pathol. 1:534–537, 1998.Google Scholar
  65. Editorial: Dangers of anti-Kell in pregnancy. Lancet 337:1319–1320, 1991.Google Scholar
  66. Eklund, J.: Embryonic rhesus-positive red cells stimulating a secondary response after early abortion. Lancet ii:748, 1981.Google Scholar
  67. Elsacker-Niele, A.M.W., Salimans, M.M.M., Weiland, H.T., Vermey-Keers, C., Anderson, M.J. and Versteeg, J.: Fetal pathology in human parvovirus B19 infection. Brit. J. Obstet. Gynaecol. 96:768–775, 1989.Google Scholar
  68. Essary, L.R., Vnencak-Jones, C.L., Manning, S.S., Olson, S.J. and Johnson, J.E.: Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods. Hum. Pathol. 29:696–701, 1998.PubMedGoogle Scholar
  69. Evron, S., Yagel, S., Samueloff, A., Margaliot, E., Burstein, P. and Sadovsky, E.: Nonimmunologic hydrops fetalis: a review of 11 cases. J. Perinat. Med. 13:147–151, 1985.PubMedGoogle Scholar
  70. Feige, A., Gille, J., Maillot, K.v. und Mulz, D.: Pränatale Diagnostik eines Steißbeinteratoms mit Hypertrophie der Plazenta. Geburtsh. Frauenheilk. 42:20–24, 1982.PubMedGoogle Scholar
  71. Fisher, R.A., Paradinas, F.J., Soteriou, B.A., Foskett, M. and Newlands, E.S.: Diploid hydatidiform moles with fetal red blood cells in molar villi. 2—genetics. J. Pathol. 181189–195, 1997.PubMedGoogle Scholar
  72. Fox, H.: The incidence and significance of nucleated erythrocytes in the foetal vessels of the mature human placenta. J. Obstet. Gynaecol. Brit. Cwlth. 74:40–43, 1967.Google Scholar
  73. Franciosi, R. and Tattersall, P.: Human parvovirus (B19) causing hydrops fetalis. Pediatr. Pathol. 7:485–486, 1987.Google Scholar
  74. Freda, V.J. and Carter, B.-A.: Placental permeability in the human for anti-A and anti-B isoantibodies. Amer. J. Obstetr. Gynecol. 84:1351–1367, 1962.Google Scholar
  75. Freda, V.J., Gorman, J.G., Galen, R.S. and Treacy, N.: The threat of Rh immunisation from abortion. Lancet i:147–148, 1970.Google Scholar
  76. Friesen, R.F., Bowman, J.M., Barnes, P.H., Grewar, D., Mcinnis, C. and Bowman, W.D.: Intrauterine transfusions for erythroblastosis. Amer. J. Obstetr. Gynecol. 97:343–339, 1967.Google Scholar
  77. Fung, T.Y., Fung, Y.M.H., Ng, P.C., Yeung, C.K. and Chang, M. Z.A.: Polyhydramnios and hypercalcemia associated with congenital mesoblastic nephroma: case report and a new appraisal. Obstet. Gynecol. 85:815–817, 1995.PubMedGoogle Scholar
  78. Gallagher, P.G., Weed, S.A., Tse, W.T., Benoit, L., Morrow, J.S., Marchesi, S.L., Mohandas, N. and Forget, B.G.: Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte β-spectrin gene. J. Clin. Invest. 95:1174–1182, 1995.PubMedGoogle Scholar
  79. Gautier, E., Benachi, A., Giovangrandi, Y., Ernault, P., Olivi, M., Gaillon, T. and Costa, J.-M.: Fetal RhD genotyping by maternal serum analysis: a two-year experience. Amer. J. Obstet. Gynecol. 192:666–669, 2005.Google Scholar
  80. Gembruch, U., Niesen, M., Hansmann, M. and Knöpple, G.: Listeriosis: A cause of non-immune hydrops fetalis. Prenat. Diagn. 7:277–282, 1987.PubMedGoogle Scholar
  81. Giacoia, G.P.: Hydrops fetalis (Fetal edema). A survey. Clin. Pediatr. 19:334–339, 1980.Google Scholar
  82. Giles, H.M., Ough, R.C.B., Darmady, E.M., Stranack, F. and Woolf, L.I.: The nephrotic syndrome in early infancy: A report of three cases. Arch. Dis. Childh. 32:167–180, 1957.PubMedGoogle Scholar
  83. Gillan, J.E., Lowden, J.A., Gaskin, K. and Cutz, E.: Congenital ascites as a presenting sign of lysosomal storage disease. J. Pediatr. 104:225–231, 1984.PubMedGoogle Scholar
  84. Ginsburg, S.J. and Groll, M.: Hydrops fetalis due to infantile Gaucher’s disease. J. Pediatr. 82:1046–1048, 1973.PubMedGoogle Scholar
  85. Gloster, E.S., Jimenez, J.F., Godoy, G., Burrows, P., Hill, D., Mollitt, D.L. and Grunow, W.A.: Nonimmune hydrops fetalis: the Arkansas Children’s Hospital experience for 1982–1983. Lab. Invest. 50:3P, 1984.Google Scholar
  86. Godra, A., Kim, D.U. and D’Cruz, C.: A 5-day-old boy with hydrops fetalis. Arch. Pathol. Lab. Med. 1271051–1052, 2003.PubMedGoogle Scholar
  87. Goldschmidt, E., Cohen, T., Isacsohn, M. and Freier, S.: Incidence of hemoglobin Bart’s in a sample of newborn from Israel. Acta Genet. (Basel) 18:361–368, 1968.Google Scholar
  88. Gonen, R., Fong, K. and Chiasson, D.A.: Prenatal sonographic diagnosis of hepatic hemangioendothelioma with secondary nonimmune hydrops fetalis. Obstet. Gynecol. 73:485–487, 1989.PubMedGoogle Scholar
  89. Gonsoulin, W., Copeland, K.L., Carpenter, R.J., Hughes, M.R. and Elder, F.B.: Fetal blood sampling demonstrating chimerism in monozygotic twins discordant for sex and tissue karyotype (46,XY and 45,X). Prenat. Diagn. 10:25–28, 1990.PubMedGoogle Scholar
  90. Goto, S., Nishi, H. and Tomoda, Y.: Blood group Rh-D factor in human trophoblast determined by immunofluorescent method. Amer. J. Obstetr. Gynecol. 137:707–712, 1980.Google Scholar
  91. Gottschalk, W. and Abramson, D.: Placental edema and fetal hydrops. A case of congenital cystic and adenomatoid malformation of the lung. Obstet. Gynecol. 10:626–631, 1957.PubMedGoogle Scholar
  92. Grannum, P.A.T., Copel, J.A., Moya, F.R., Scioscia, A.L., Robert, J.A., Winn, H.N., Coster, B.C., Burdine, C.B. and Hobbins, J. C.: The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia. Amer. J. Obstetr. Gynecol. 158:914–919, 1988.Google Scholar
  93. Greenberg, F., Carpenter, R.J. and Ledbetter, D.H.: Cystic hygroma and hydrops fetalis in a fetus with trisomy 13. Clin. Genet. 24:389–391, 1983.PubMedGoogle Scholar
  94. Grimes, D.A., Geary, F.H. and Hatcher, R.A.: Rh immunoglobulin utilization after ectopic pregnancy. Amer. J. Obstetr. Gynecol. 140:246–249, 1981.Google Scholar
  95. Groves, G.R. and Baskett, T.F.: Nonimmune hydrops fetalis: Antenatal diagnosis and management. Amer. J. Obstet. Gynecol. 148:563–569, 1984.Google Scholar
  96. Gray, E.S.: Human parvovirus infection. J. Pathol. 153:310–311, 1987.PubMedGoogle Scholar
  97. Gray, E.S.: Mesoblastic nephroma and non-immunological hydrops fetalis. Letter to the editor. Pediatr. Pathol. 9:607–609, 1989.PubMedGoogle Scholar
  98. Gray, E.S., Davidson, R.J.L. and Anand, A.: Human parvovirus and fetal anaemia. Lancet i:1144, 1987.Google Scholar
  99. Gray, G.R., Towell, M.E., Wright, V.J. and Hardwick, D.F.: Thalassemic hydrops fetalis in two Chinese-Canadian families. Canad. Med. Assoc. J. 107:1186–1190, 1972.PubMedGoogle Scholar
  100. Green, D.W., Donovan, E.F. and Wood, B.P.: Radiological cases of the month. Amer. J. Dis. Child. 144:93–94, 1990.PubMedGoogle Scholar
  101. Greenberg, F., Faucett, A., Rose, E., Bancalari, L., Kardon, N.B., Mizejewski, G., Haddon, J.E. and Alpert, E.: Congenital deficiency of α-fetoprotein. Amer. J. Obstet. Gynecol. 167:509–511, 1992.Google Scholar
  102. Gropp, A.: Fetal hydrops in chromosome disorders as principle of damage in developmental pathology. Clinical observations in man and experimental studies in the mouse. Chapter 8 in, One Medicine, O.A. Ryder and M.L. Byrd, eds. pp 84–95. Springer-Verlag, New York, 1984.Google Scholar
  103. Guntheroth, W.G., Cyr, D.R., Mack, L.A., Benedetti, T., Lenke, R.R. and Petty, C.N.: Hydrops from reciprocating atrioventricular tachycardia in a 27-week fetus requiring quinidine for conversion. Obstet. Gynecol. 66:29S–33S, 1985.PubMedGoogle Scholar
  104. Guy, G., Coady, D.J., Jansen, V., Snyder, J. and Zinberg, S.: α-Thalassemia hydrops fetalis: Clinical and ultrasonographic considerations. Amer. J. Obstet. Gynecol. 153:500–504, 1985.Google Scholar
  105. Hall, S.M., Cohen, B.J., Mortimer, P.P., Caul, E.O., Cradock-Watson, J., Anderson, M.J., Pattison, J.R., Shirley, J.A. and Peto, T.E.A.: Prospective study of human parvovirus (B 19) infection in pregnancy. Brit. Med. J. 300:1166–1170, 1990.Google Scholar
  106. Hallak, M., Neerhof, M.G., Perry, R., Nazir, M. and Hulka, J.C.: Fetal supraventricular tachycardia and hydrops fetalis: Combined intensive, direct, and transplacental therapy. Obstet. Gynecol. 78:523–525, 1991.PubMedGoogle Scholar
  107. Hardy, L., Hansen, J.L., Kushner, J.P. and Knisely, A.S.: Neonatal hemochromatosis. Genetic analysis of transferrin-receptor, H-apoferritin, and L-apoferritin loci and of the human leukocyte antigen class I region. Amer. J. Pathol. 137:149–153, 1991.Google Scholar
  108. Harger, J.H., Adler, S.P., Koch, W.C. and Harger, G.F.: Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms. Obstet. Gynecol. 91:413–420, 1998.PubMedGoogle Scholar
  109. Harkavy, K.L. and Scanlon, J.W.: Hydrops fetalis in a parabiotic, acardiac twin. Amer. J. Dis. Child. 132:638–639, 1978.Google Scholar
  110. Harman, C.R., Bowman, J.M., Menticoglou, S.M., Pollock, J.M. and Manning, F.A.: Profound fetal thrombocytopenia in rhesus disease: Serious hazard at intravascular transfusion. Lancet ii:741–742, 1988.Google Scholar
  111. Hatjis, C.G.: Nonimmunologic fetal hydrops associated with hyperreactio luteinalis. Obstetr. Gynecol. 65:11S–13S, 1985.Google Scholar
  112. Hellman, L.M. and Hertig, A.T.: Pathological changes in the placenta associated with erythroblastosis of the fetus. Amer. J. Pathol. 14:111–120, 1937.Google Scholar
  113. Hendricks, S.K., Sorensen, T.K. and Baker, E.R.: Trisomy 21, fetal hydrops, and anemia: Prenatal diagnosis of transient myeloproliferative disorder? Obstet. Gynecol. 82:703–705, 1993.PubMedGoogle Scholar
  114. Herman, A., Bukovsky, Y., Benson, L., Weinraub, Z. and Caspi, E.: Intrapartum use of fetal scalp hematocrit in the diagnosis of profound fetal anemia caused by fetomaternal hemorrhage. Amer. J. Obstet. Gynecol. 157:1182–1183, 1987.Google Scholar
  115. Hogge, W.A., Hogge, J.S., Schnatterly, P.T., Sun, C.J. and Blitzer, M.G.: Congenital nephrosis: Detection of index cases through maternal serum a-fetoprotein screening. Amer. J. Obstet. Gynecol. 167:1330–1333, 1992.Google Scholar
  116. Holzgreve, W., Miny, P., Anderson, R. and Golbus, M.S.: Experience with 8 cases of prenatally diagnosed sacrococcygeal teratomas. Fetal Therapy 2:88–94, 1987.PubMedGoogle Scholar
  117. Horowitz, A., Cohen, T., Goldschmidt, E. and Levene, C.: Thalassemia among Kurdish Jews in Israel. Brit. J. Haematol. 12:555–568, 1966.Google Scholar
  118. Houston, C.S. and Brown, A.B.: An unusual complication of intrauterine transfusion. Canad. Med. Ass. J. 94:1274–1277, 1966.Google Scholar
  119. Hoyer, J.R., Michael, A.F., Good, R.A. and Vernier, R.L.: The nephrotic syndrome of infancy: Clinical, morphologic, and immunologic studies of four infants. Pediatrics 40:233–246, 1967.PubMedGoogle Scholar
  120. Hoyer, J.R., Mauer, S.M., Kjellstrand, C.M., Buselmeier, T.J., Simmons, R.L., Michael, A.F., Najarian, J.S. and Vernier, R.L.: Successful renal transplantation in 3 children with congenital nephrotic syndrome. Lancet i:1410–1413, 1973.Google Scholar
  121. Humphrey, W., Magoon, M. and O’Shaughnessy, R.: Severe nonimmune hydrops secondary to parvovirus B-19 infection: Spontaneous reversal in utero and survival of a term infant. Obstet. Gynecol. 78:900–902, 1991.PubMedGoogle Scholar
  122. Hung, P.-L., Huang, C.-C. and Huang, T.-S.: Nephrotic syndrome in a Chinese infant. Amer. J. Dis. Childr. 131:557–559, 1977.Google Scholar
  123. Hutchison, A.A., Drew, J.H., Yu, V.Y.H., Williams, M.L., Fortune, D.W. and Beischer, N.A.: Nonimmunologic hydrops fetalis: A review of 61 cases. Obstet. Gynecol. 59:347–352, 1982.PubMedGoogle Scholar
  124. Iakovtsova, A.G.: Morphologic changes in the placenta in isoantigenic incompatibility of maternal and fetal blood. Pediatr. Akhush. Ginekol. 1:53–55, 1964.Google Scholar
  125. Imakita, M., Yutani, C., Ishibashi-Ueda, H., Murakami, M. and Chiba, Y.: A case of hydrops fetalis due to placental chorangioma. Acta Pathol. Japan 38:941–945, 1988.Google Scholar
  126. Ing, R.Y.K., Crookston, J.H., Dworatzek, J.A. and Burnie, K.L.: Alpha thalassemia: Five cases of hemoglobin H disease in Oriental-Canadian families. Canad. Med. Ass. J. 99:49–56, 1968.PubMedGoogle Scholar
  127. Irani, D., Kim, H.S., El-Hibri, H., Dutton, R.V., Beaudet, A. and Armstrong, D.: Postmortem observations on β-glucuronidase deficiency presenting as hydrops fetalis. Ann. Neurol. 14:486–490, 1983.PubMedGoogle Scholar
  128. Ivemark, B.I., Högman, C., Rudert, P.O. and Andersen, B.: Kell-iso-immunization as the cause of fatal erythroblastosis fetalis. Acta Pathol. Microbiol. Scand. 45:193–202, 1959.Google Scholar
  129. Jackson, M.R., Carney, E.W., Lye, S.J. and Knox Ritchie, J.W.: Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15:341–353, 1994.PubMedGoogle Scholar
  130. James, G.B.: Histology of the placenta after repeated intrauterine transfusions. Proc. Roy. Soc. Med. 63:54, 1970.PubMedGoogle Scholar
  131. Jarkowski, T.L., Rosenblatt, M., Wolf, P. and Pearson, B.: Tissue-fixed antigens of the Rh blood group system in placentae and fetuses; with particular reference to hemolytic disease of the newborn. Lab. Invest. 13:937, 1964.Google Scholar
  132. Jauniaux, E., Maldergem L.v., Munter, C.de, Moscoso, G. and Gillerot, Y.: Nonimmune hydrops fetalis associated with genetic abnormalities. Obstet. Gynecol. 75:568–572, 1990.PubMedGoogle Scholar
  133. Johnson, P., Sharland, G., Allan, L.D., Tynan, M.J. and Maxwell, D.J.: Umbilical venous pressure in nonimmune hydrops fetalis: Correlation with cardiac size. Amer. J. Obstet. Gynecol. 167:1309–1313, 1992.Google Scholar
  134. Jones, C.J.P. and Fox, H.: An ultrastructural study of the placenta in materno-fetal rhesus incompatibility. Virchows Arch. Pathol. Anat. Histol. 379:229–241, 1978.Google Scholar
  135. Jones, D.E.D., Pritchard, K.I., Gioannini, C.A., Moore, D.T. and Bradford, W.D.: Hydrops fetalis associated with idiopathic arterial calcification. Obstet. Gynecol. 39:435–440, 1972.PubMedGoogle Scholar
  136. Jonxis, J.H.P.: The development of hemoglobin. Pediatr. Clinics North Amer. 12:535–550, 1965.Google Scholar
  137. Jordan, J.A.: Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Amer. J. Obstet. Gynecol. 174:37–42, 1996.Google Scholar
  138. Jorgensen, J.: Rhesus-antibody development after abortion. Lancet ii:1253–1254, 1969.Google Scholar
  139. Kamat, B.R., Greco, M.A. and Demopoulos, R.I.: Immunocytochemichal staining patterns of placentas associated with hydrops fetalis. Int. J. Gynecol. Pathol. 8:246–254, 1989.PubMedGoogle Scholar
  140. Kan, Y.W., Allen, A. and Lowenstein, L.: Hydrops fetalis with alpha thalassemia. NEJM 276:18–23, 1967.PubMedGoogle Scholar
  141. Kan, Y.W., Forget, B.G. and Nathan, D.G.: Gamma-beta thalassemia: A cause of hemolytic disease of the newborn. NEJM 286:129–134, 1972.PubMedGoogle Scholar
  142. Kan, Y.W., Golbus, M.S. and Dozy, A.M.: Prenatal diagnosis of α-thalassemia: Clinical application of molecular hybridization. NEJM 295:1165–1167, 1976.PubMedGoogle Scholar
  143. Kaplan, C., Lane, B., Miller, F., Baker, D. and Trunca, C.: Renal pathology of prenatally diagnosed nephrosis. Pediatr. Pathol. 3:271–281, 1985.PubMedGoogle Scholar
  144. Kinney, J.S., Anderson, L.J., Farrar, J., Strikas, R.A., Kumar, M.L., Kliegman, R.M., Sever, J.L., Hurwitz, E.S. and Sikes, R.K.: Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J. Infect. Dis. 157:663–667, 1988.PubMedGoogle Scholar
  145. Klein, A.M., Holzman, I.R. and Austin, E.M.: Fetal tachycardia before the development of hydrops-attempted cardio-version: a case report. Amer. J. Obstet. Gynecol. 134:347–348, 1979.Google Scholar
  146. Kleinman, C.S., Donnerstein, R.L., Devore, G.R., Jaffe, C.C., Lynch, D.C., Berkowitz, R.L., Talner, N.S. and Hobbins, J.C.: Fetal echocardiography for evaluation of in utero congestive heart failure. A technique for study of nonimmune hydrops. NEJM 306:568–575, 1982.PubMedGoogle Scholar
  147. Knisely, A.S.: Placental siderosis in maternal β-thalassemia. Amer. J. Obstet. Gynecol. 162:1638–1639, 1990a.Google Scholar
  148. Knisely, A.S.: Parvovirus B19 infection in the fetus. Lancet 336:443, 1990b.PubMedGoogle Scholar
  149. Knisely, A.S., O’Shea, P., McMillan, P., Singer, D.B. and Magid, M.S.: Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis. Pediatr. Pathol. 8:163–170, 1988.PubMedGoogle Scholar
  150. Koffler, H., Papile, L.-A. and Burstein, R.: Congenital chylothorax: two cases associated with maternal polyhydramnios. Amer. J. Dis. Childr. 132:638, 1978.Google Scholar
  151. Kohga, S., Nambu, T., Tanaka, K., Benirschke, K., Feldman, B.H. and Kishikawa, T.: Hypertrophy of the placenta and sacrococcygeal teratoma. Report of two cases. Virchows Arch. A Pathol. Anat. Histol. 386:223–229, 1980.PubMedGoogle Scholar
  152. Kohler, H.G. and Rymer, B.: Congenital cystic malformation of the lung and its relation to hydramnios. J. Obstet. Gynaecol. Brit. Cwlth. 80:130–134, 1973.Google Scholar
  153. Kovacs, B.W., Carlson, D.E., Shahbahrami, M.S. and Platt, L.D.: Prenatal diagnosis of human parvovirus B 19 in nonimmune hydrops fetalis by polymerase chain reaction. Amer. J. Obstet. Gynecol. 167:461–466, 1992.Google Scholar
  154. Krause, J.R., Penchansky, L. and Knisely, A.S.: Morphological diagnosis of parvovirus B19 infection. Arch. Pathol. Lab. Med. 116:178–180, 1992.PubMedGoogle Scholar
  155. Kuhlmann, R.S., Warsof, S.L., Levy, D.L., Flake, A.J. and Harrison, M.R.: Fetal therapy 2:95–100, 1987.PubMedGoogle Scholar
  156. Lacro, R.V., Jones, K.L. and Benirschke, K.: Coarctation of the aorta in Turner syndrome: a pathologic study of fetuses with nuchal hygromas, hydrops fetalis, and female genitalia. Pediatrics 81:445–451, 1988.PubMedGoogle Scholar
  157. Lage, J.M.: Placentomegaly with massive hydrops of placental stem villi, diploid DNA content, and omphaloceles: possible association with Beckwith-Wiedemann syndrome. Human Pathol. 22:591–597, 1991.Google Scholar
  158. Landrum, B.G., Johnson, D.E., Ferrara, B., Boros, S.J. and Thompson, T.R.: Hydrops fetalis and chromosomal trisomies. Amer. J. Obstet. Gynecol. 154:1114–1115, 1986.Google Scholar
  159. Langer, J.C., Harrison, M.R., Schmidt, K.G., Silverman, N.H., Anderson, R.L., Goldberg, J.D., Filly, R.A., Crombleholme, T.M., Longaker, M.T. and Golbus, M.S.: Fetal hydrops and death from sacrococcygeal teratoma: rationale for fetal surgery. Amer. J. Obstet. Gynecol. 160:1145–1150, 1989.Google Scholar
  160. Lallemand, A.V., Doco-Fenzy, M. and Gaillard, D.A.: Investigation of nonimmune hydrops fetalis: multidisciplinary studies are necessary for diagnosis—review of 94 cases. Ped. Developm. Pathol. 2:432–439, 1999.Google Scholar
  161. Lam, Y.-H., Tang, M.H.-Y., Lee, C.-P. and Tse, H.-Y.: Prenatal ultrasonographic prediction of homozygous type 1 α-thalassemia at 12 to 13 weeks of gestation. Amer. J. Obstetr. Gynecol. 180:148–150, 1999.Google Scholar
  162. Laros, R.K. and Kalstone, C.E.: Sickle cell β-thalassemia and pregnancy. Obstet. Gynecol. 37:67–71, 1971.PubMedGoogle Scholar
  163. Leake, R.D., Strimling, B. and Emmanouilidis, G.C.: Intrauterine cardiac failure with hydrops fetalis. Case report in a twin with the hypoplastic left heart syndrome and review of the literature. Clin. Pediatr. 12:649–651, 1973.Google Scholar
  164. Lebo, R.V., Saiki, R.K., Swanson, K., Montano, M.A., Erlich, H.A. and Golbus, M.S.: Prenatal diagnosis of α-thalassemia by polymerase chain reaction and dual restriction enzyme analysis. Hum. Genet. 85:293–299, 1990.PubMedGoogle Scholar
  165. Lee, J.-N., Huang, S.-C., Ouyang, P.-C. and Chard, T,: Circulating placental proteins in pregnancies complicated by Rh isoimmunization. Obstetr. Gynecol. 64:131–132, 1984.Google Scholar
  166. Leggat, H.M., Gibson, J.M., Barron, S.L. and Reid, M.M.: Anti-Kell in pregnancy. Brit. J. Obstetr. Gynaecol. 98:162–165, 1991.Google Scholar
  167. Leventhal, M.L. and Wolf, A.M.: Erythroblastosis (hydrops) fetalis from Kell sensitization. Amer. J. Obstetr. Gynecol. 71:452–454, 1956.Google Scholar
  168. Lie-Injo, L.E.: Haemoglobin of new-born infants in Indonesia. Nature 183:1125–1126, 1959.Google Scholar
  169. Lie-Injo, L.E.: Alpha-chain thalassemia and hydrops fetalis in Malaysia; report of 5 cases. Blood 20:581–590, 1962.PubMedGoogle Scholar
  170. Lie-Injo, L.E., Lopez, C.G. and Dutt, A.K.: Pathological findings in hydrops foetalis due to alpha-thalassemia: a review of 32 cases. Trans. Roy. Soc. Tropical Med. Hyg. 62:874–879, 1968.Google Scholar
  171. Lingman, G., Lundström, N.R., Marsal, K. and Ohrlander, S.: Fetal cardiac arrhythmia-clinical outcome in 113 cases. Acta Obstet. Gynecol. Scand. 65:263–267, 1986.PubMedGoogle Scholar
  172. Louderback, A.L. and Shanbrom, E.: Hemoglobin electrophoresis. JAMA 202:718–719, 1967.PubMedGoogle Scholar
  173. Luca, E.C. de, Casadei, A.M., Pascone, R., Tardi, C. and Pacioni, C.: Maternofetal transfusion during delivery and sensitization of newborn against the rhesus D-antigen. Vox Sanguinis 34:241–243, 1978.Google Scholar
  174. Lynn, A.A.A., Parry, S.I., Morgan, M.A. and Mennuti, M.T.: Disseminated congenital neuroblastoma involving the placenta. Arch. Pathol. Lab. Med. 121:741–744, 1997.PubMedGoogle Scholar
  175. Macafee, C.A.J., Fortune, D.W. and Beischer, N.A.: Nonimmunological hydrops fetalis. J. Obstet. Gynaecol. Brit. Cwlth. 77:226–237, 1970.Google Scholar
  176. Machin, G.A.: Hydrops revisited: Literature review of 1,414 cases published in the 1980s. Amer. J. Med. Genet. 34:366–390, 1989.Google Scholar
  177. Macgregor, S.N., Socol, M.L., Pielet, B.W., Sholl, J.T. and Minogue, J.P.: Prediction of fetoplacental blood volume in isoimmunized pregnancy. Amer. J. Obstetr. Gynecol. 159:1493–1497, 1988.Google Scholar
  178. Maeda, H., Shimokawa, H., Saton, S., Nakano, H. and Nunoue, T.: Nonimmunologic hydrops fetalis resulting from intrauterine human parvovirus B-19 infection: report of two cases. Obstet. Gynecol. 72:482–485, 1988.PubMedGoogle Scholar
  179. Maidman, J.E., Yeager, C., Anderson, V., Makabali, G., O’Grady, J.P., Arce, J. and Tishler, D.M.: Prenatal diagnosis and management of nonimmunologic hydrops fetalis. Obstet. Gynecol. 56:571–576, 1980.PubMedGoogle Scholar
  180. Mallmann, P., Gembruch, U., Mallmann, R. and Hansmann, M.: Investigations into a possible immunological origin of idiopathic non-immune hydrops fetalis and initial results of prophylactic immune treatment of subsequent pregnancies. Acta Obstet. Gynecol. Scand. 70:35–40, 1991.PubMedGoogle Scholar
  181. Manning, F.A., Heaman, M., Boyce, D. and Carter, L.J.: Intrauterine fetal tachypnea. Obstet. Gynecol. 58:398–400, 1981.PubMedGoogle Scholar
  182. Manning, F.A., Bowman, J.M., Lange, I.R. and Chamberlain, P. F.: Intrauterine transfusion in an Rh-immunized twin pregnancy: a case report of successful outcome and a review of the literature. Obstetr. Gynecol. 65:2S–6S, 1985.Google Scholar
  183. Mark, Y., Rogers, B.B. and Oyer, C.E.: Diagnosis and incidence of fetal parvovirus infection in an autopsy series: II. DNA amplification. Pediatr. Pathol. 13:381–386, 1993.PubMedGoogle Scholar
  184. Markenson, G., Correia, L.A., Cohn, G., Bayer, L. and Kanaan, C.: Parvoviral infection associated with increased nuchal translucency: a case report. J. Perinatol. 2:129–131, 2000.Google Scholar
  185. Matthews, C.D., Matthews, A.E.B. and Gilbey, B.E.: Antibody development in rhesus-negative patients following abortion. Lancet ii:318–319, 1969.Google Scholar
  186. McCowan, L.M.E. and Becroft, D.M.O.: Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet. Gynecol. 83:813–817, 1994.PubMedGoogle Scholar
  187. McCoy, M.C., Katz, V.L., Gould, N. and Kuller, J.A.: Nonimmune hydrops after 20 weeks’ gestation: review of 10 years’ experience with suggestions for management. Obstet. Gynecol. 85:578–582, 1995.PubMedGoogle Scholar
  188. McFadden, D.E. and Taylor, G.P.: Cardiac abnormalities and nonimmune hydrops fetalis: a coincidental, not causal, relationship. Pediatr. Pathol. 9:11–17, 1989.PubMedGoogle Scholar
  189. Meizner, I., Levy, A., Carmi, R. and Robinsin, C.: Niemann-Pick disease associated with nonimmune hydrops fetalis. Amer. J. Obstet. Gynecol. 163:128–129, 1990.Google Scholar
  190. Mentzer, W.C. and Collier, E.: Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid. J. Pediatr. 86:565–567, 1975.PubMedGoogle Scholar
  191. Metzman, R., Anand, A., DeGiulio, P.A. and Knisely, A.S.: Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J. Pediat. Gastroenterol. Nutr. 9:119–114, 1989.Google Scholar
  192. Miller, D.F. and Petrie, S.J.: Fatal erythroblastosis fetalis secondary to ABO incompatibility. Obstetr. Gynecol. 22:773–777, 1963.Google Scholar
  193. Miller, P.D., Smith, B.C. and Marinoff, D.N.: Theca-lutein ovarian cysts associated with homozygous α-thalassemia. Amer. J. Obstet. Gynecol. 157:912–914, 1987.Google Scholar
  194. Milner, P.F., Clegg, J.B. and Weatherall, D.J.: Haemoglobin-H disease due to a unique haemoglobin variant with an elongated α-chain. Lancet i:729–732, 1971.Google Scholar
  195. Milunsky, A., Alpert, E., Frigoletto, F.D., Driscoll, S.G., McCluskey, R.T. and Colvin, R.B.: Prenatal diagnosis of the congenital nephrotic syndrome. Pediatrics 59:770–773, 1977.PubMedGoogle Scholar
  196. Mittendorf, R. and Williams, M.A.: RHo(D) immunoglobulin (RhoGAM): How it came into being. Obstetr. Gynecol. 77:301–303, 1991.Google Scholar
  197. Moerman, P., Fryns, J.P., Goddeeris, P. and Lauweryns, J.M.: Nonimmunologic hydrops fetalis. A study of ten cases. Arch. Pathol. Lab. Med. 106:635–640, 1982.PubMedGoogle Scholar
  198. Mogilner, B.M., Ashkenazy, M., Borenstein, R. and Lancet, M.: Hydrops fetalis caused by maternal indomethacin treatment. Acta Obstet. Gynecol. Scand. 61:183–185, 1982.PubMedGoogle Scholar
  199. Moller, J.H., Lynch, R.P. and Edwards, J.E.: Fetal cardiac failure resulting from congenital anomalies of the heart. J. Pediatr. 68:699–703, 1966.PubMedGoogle Scholar
  200. Mollison, P.L.: Suppression of Rh-immunization by passively administered anti-Rh. Br. J. Haematol. 14:1–4, 1968.PubMedGoogle Scholar
  201. Montemagno, U., Stefano, M.di e Cardone, A.: Aspetti istoimmunologici della placenta nella incompatibilita Rh. In, Simpos. sui Problemi Ostetrico-Pediatrici della Sofferenza Fetale. Offic. Grafiche Stianti-Sanscasciano, Siena, Italy, 1966. pp. 649–655.Google Scholar
  202. Mor, Z., Schreyer, P., Wainraub, Z., Hayman, E. and Caspi, E.: Nonimmune hydrops fetalis associated with angioosteohypertrophy (Klippel-Trenaunay) syndrome. Amer. J. Obstet. Gynecol. 159:1185–1186, 1988.Google Scholar
  203. Morey, A.L., Nicolini, U., Welch, C.R., Economides, D., Chamberlain, P.F. and Cohen, B.J.: Parvovirus B 19 infection and transient fetal hydrops. Lancet 337:496, 1991.PubMedGoogle Scholar
  204. Moss, T.J. and Kaplan, L.: Association of hydrops fetalis with congenital neuroblastoma. Amer. J. Obstet. Gynecol. 132:905–906, 1978.Google Scholar
  205. Mostoufi-Zadeh, M., Weiss, L.M. and Driscoll, S.G.: Nonimmune hydrops fetalis: a challenge in perinatal pathology. Human Pathol. 16:785–789, 1985.Google Scholar
  206. Moya, F.R., Grannum, P.A.T., Widness, J.A., Clemons, G.K., Copel, J.A. and Hobbins, J.C.: Erythropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet. Gynecol. 82:353–358, 1993.PubMedGoogle Scholar
  207. Murray, S. and Barron, S.L.: Rhesus isoimmunization after abortion. Brit. Med. J. iii:87–89, 1971.Google Scholar
  208. Naeye, R.L.: New observations in erythroblastosis fetalis. JAMA 200:105–110, 1967.Google Scholar
  209. Nakamura, Y., Komatsu, Y., Yano, H., Kitazono, S., Hosokawa, Y., Fukuda, S., Kawano, S., Nagasue, N., Matsunaga, T., Aiko, Y., Hashimoto, T. and Morimatsu, M.: Nonimmunologic hydrops fetalis: a clinicopathological study of 50 autopsy cases. Pediatr. Pathol. 7:19–30, 1987.PubMedGoogle Scholar
  210. Nakayama, R., Yamada, D., Steinmiller, V., Hsia, E. and Hale, R.W.: Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet. Gynecol. 67:176–180, 1986.PubMedGoogle Scholar
  211. Nalbandian, R.M., Henry, R.L., Camp, F.R., Wolf, P.L. and Evans, T.N.: Embryonic, fetal, and neonatal hemoglobin synthesis: relationship to abortion and thalassemia. Obstet. Gynecol. Survey 26:185–191, 1971.Google Scholar
  212. Nathan, D.G.: Thalassemia: a progress report on applied molecular biology. NEJM 288:1122–1123, 1973.PubMedGoogle Scholar
  213. Nelson, A., Peterson, L.A., Frampton, B. and Sly, W.S.: Mucopolysaccharidosis VII (β-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J. Pediatr. 101:574–576, 1982.PubMedGoogle Scholar
  214. Nerlich, A., Schwarz, T.F., Roggendorf, M., Roggendorf, H., Ostermeyer, E., Schramm, T. and Gloning, K.-P.: Parvovirus B19-infected erythroblasts in fetal cord blood. Lancet 337:310, 1991.PubMedGoogle Scholar
  215. Newton, E.R., Louis, F., Dalton, M.E. and Feingold, M.: Fetal neuroblastoma and catecholamine-induced maternal hypertension. Obstet. Gynecol. 65:49S–52S, 1985.PubMedGoogle Scholar
  216. Nicolaides, K.H., Soothill, P.W., Clewell, W.H., Rodeck, C.H., Mibashan, R.S. and Campbell, S.: Fetal haemoglobin measurement of red cell isoimmunization. Lancet i:1073–1075, 1988a.Google Scholar
  217. Nicolaides, K.H., Thilaganathan, B., Rodeck, C.H. and Mibashan, R.S.: Erythroblastosis and reticulocytosis in anemic fetuses. Amer. J. Obstetr. Gynecol. 159:1063–1065, 1988b.Google Scholar
  218. Nicolaides, K.H., Thilaganathan, B. and Mibashan, R.S.: Cordocentesis in the investigation of fetal erythropoiesis. Amer. J. Obstetr. Gynecol. 161:1197–1200, 1989.Google Scholar
  219. Nicolini, U., Talbert, D.G., Fisk, N.M. and Rodeck, C.H.: Pathophysiology of pressure changes during intrauterine transfusion. Amer. J. Obstetr. Gynecol. 160:1139–1145, 1989.Google Scholar
  220. Nimrod, C., Davies, D., Harder, J., Iwanicki, S., Kondo, C., Takahashi, Y., Maloney, J., Persaud, D. and Nicholson, S.: Ultrasound evaluation of tachycardia-induced hydrops in the fetal lamb. Amer. J. Obstet. Gynecol. 157:655–659, 1987.Google Scholar
  221. Novak, P.M., Sander, M., Yang, S.S. and Oeyen, P.T.v.: Report of fourteen cases of nonimmune hydrops fetalis in association with hemorrhagic endovasculitis of the placenta. Amer. J. Obstet. Gynecol. 165:945–950, 1991.Google Scholar
  222. Oetama, B.K., Tucay, R.F. and Morgan, D.L.: Nonimmune hydrops in a newborn. Arch. Pathol. Lab. Med. 125:1609–1610, 2001.PubMedGoogle Scholar
  223. Ohyama, M., Kobayashi, S., Aida, N., Toyoda, Y., Ijiri, R. and Tanaka, Y.: Congenital neuroblastoma diagnosed by placental examination. Med. Ped. Oncol. 33:430–431, 1999.Google Scholar
  224. Olson, R.W., Nishibatake, M., Arya, S. and Gilbert, E.F.: Nonimmunologic hydrops fetalis due to intrauterine closure of fetal foramen ovale. In, Genetic Aspects of Developmental Pathology. E.F. Gilbert, ed. Birth Defects: Original Article Series. 23(1):433–442, 1987. Alan R. Liss, New York.Google Scholar
  225. Orkin, S.H. and Michelson, A.: Partial deletion of the α-globin structural gene in human α-thalassemia. Nature 286:538–540, 1980.PubMedGoogle Scholar
  226. Orkin, S.H. and Nathan, D.G.: Current concepts in genetics. NEJM 295:710–714, 1976.PubMedGoogle Scholar
  227. Östör, A.G. and Fortune, D.W.: Tuberous sclerosis initially seen as hydrops fetalis. Report of a case and review of the literature. Arch. Pathol. Lab. Med. 102:34–39, 1978.PubMedGoogle Scholar
  228. Oudesluys-Murphy, A.M.: Nonimmune hydrops fetalis in Noonan’s syndrome. Amer. J. Dis. Childr. 141:478–479, 1987.Google Scholar
  229. Özmen, S., Seçkin, N., Turhan, N.Ö., Dilmen, G. and Dilmen. U.: Fetal methemoglobinemia: a cause of nonimmune hydrops. Amer. J. Obstet. Gynecol. 173:232–233, 1995.Google Scholar
  230. Paradinas, F.J., Fisher, R.A., Browne, P. and Newlands, E.S.: Diploid hydatidiform moles with fetal red blood cells in molar villi. 1—pathology, incidence, and prognosis. J. Pathol. 181:183–188, 1997.PubMedGoogle Scholar
  231. Pattison, J.R., Jones, S.E., Hodgson, J., Davis, L.R., White, J.M., Stroud, C.E. and Murtoza, L.: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet i:664–665, 1981.Google Scholar
  232. Pattison, N. and Roberts, A.: The management of severe erythroblastosis fetalis by fetal transfusion: survival of transfused adult erythrocytes in the fetus. Obstetr. Gynecol. 74:901–904, 1989.Google Scholar
  233. Pearson, H.A., Shanklin, D.R. and Brodine, C.R.: Alphathalassemia as cause of nonimmunological hydrops. Amer. J. Dis. Childr. 109:168–172, 1965.Google Scholar
  234. Perkins, D.G., Kopp, C.M. and Haust, M.D.: Placental infiltration in congenital neuroblastoma: a case study with ultrastructure. Histopathol. 4:383–389, 1980.Google Scholar
  235. Perlin, B.M., Pomerance, J.J. and Schifrin, B.S.: Nonimmunologic hydrops fetalis. Obstet. Gynecol. 57:584–588, 1981.PubMedGoogle Scholar
  236. Perkins, R.P.: Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole. Amer. J. Obstet. Gynecol. 111:379–381, 1971.Google Scholar
  237. Peschle, C., Mavilio, F., Care, A., Migliaccio, G., Migliaccio, A.R., Salvo, G., Samoggia, P., Petti, S., Guerriero, R., Marinucci, M., Lazzaro, D., Russo, G. and Mastroberardino, G.: Haemoglobin switching in human embryos: asynchrony of ∫ → α and epsilon → gamma-globin switches in primitive and definitive erythropoietic lineage. Nature 313:235–238, 1985.PubMedGoogle Scholar
  238. Peters, M.T. and Nicolaides, K.H.: Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet. Gynecol. 75:501–504, 1990.PubMedGoogle Scholar
  239. Pielet, B.W., Socol, M.L., Macgregor, S.N., Ney, J.A. and Dooley, S.L.: Cordocentesis: an appraisal of risks. Amer. J. Obstetr. Gynecol. 159:1497–1500, 1988.Google Scholar
  240. Pillay, D., Patou, G., Hurt, S., Kibbler, C.C. and Griffiths, P.D.: Parvovirus B19 outbreak in a children’s ward. Lancet 339:107–109, 1992.PubMedGoogle Scholar
  241. Pilz, I., Schweikhart, G. und Kaufmann, P.: Zur Abgrenzung normaler, artefizieller und pathologischer Strukturen in reifen menschlichen Plazentarzotten. III. Morphometrische Untersuchungen bei Rhesus-Inkompabilität. Arch. Gynecol. 229:137–154, 1980.PubMedGoogle Scholar
  242. Pootrakul, S., Wasi, P. and Na-Nakorn, S.: Haemoglobin Bart’s hydrops foetalis in Thailand. Ann. Hum. Genet. 30:293–311, 1967.PubMedGoogle Scholar
  243. Porter, H.J., Quantrill, A.M. and Flehming K.A.: B19 parvovirus infection of myocardial cells. Lancet i:535–536, 1988.Google Scholar
  244. Price, J.R.: Rh sensitization by hydatidiform mole. NEJM 278:1021, 1968.PubMedGoogle Scholar
  245. Pringle, K.C., Weiner, C.P., Soper, R.T. and Kealey, P.: Sacrococcygeal teratoma. Fetal Therapy 2:80–87, 1987.PubMedGoogle Scholar
  246. Pryde, P.G., Nugent, C.E., Pridjian, G., Barr, M. and Faix, R.G.: Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet. Gynecol. 79:859–861, 1992.PubMedGoogle Scholar
  247. Public Health Laboratory Service Working Party on Fifth Disease: prospective study of human parvovirus (B-19) infection in pregnancy. Brit. Med. J. 300:1166–1170, 1990.Google Scholar
  248. Pustilnik, T.B. and Cohen, A.W.: Parvovirus B19 infection in a twin pregnancy. Obstet. Gynecol. 83:834–836, 1994.PubMedGoogle Scholar
  249. Queenan, J.T. and Douglas, G.R.: Intrauterine transfusion: a preliminary report. Obstetr. Gynecol. 25:308–321, 1965.Google Scholar
  250. Queenan, J.T. and Nakamoto, M.: Postpartum immunization: the hypothetical hazard of manual removal of the placenta. Report of a study. Obstetr. Gynecol. 23:392–395, 1964.Google Scholar
  251. Rabinowitz, P., Harris, e.J. and Friedman, I.S.: Theca-lutein cysts of the ovaries. A case of erythroblastosis with abruptio placentae and acute renal failure. JAMA 177: 509–510, 1961.PubMedGoogle Scholar
  252. Radunovic, N., Lockwood, C.J., Alvarez, M., Plecas, D., Chitkara, U. and Berkovitz, R.L.: The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstetr. Gynecol. 79:390–393, 1992.Google Scholar
  253. Ravindranath, Y., Paglia, D.E., Warrier, I., Valentine, W., Nakatani, M. and Brockway, R.A.: Glucose phosphate isomerase deficiency as a cause of hydrops fetalis. NEJM 316:258–261, 1987.PubMedGoogle Scholar
  254. Reece, E.A., Gabrielli, S., Abdalla, M., O’Connor, T.Z. and Hobbins, J.C.: Reassessment of the utility of fetal umbilical vein diameter in the management of isoimmunization. Amer. J. Obstetr. Gynecol. 159:937–938, 1988.Google Scholar
  255. Rice, G.E., Mostoufi-Zadeh, M., Kolodny, E.H. and Driscoll, S.G.: Hydrops fetalis in Gaucher’s disease. Teratology 29:53A–54A, 1984.Google Scholar
  256. Rodeck, C.H., Nicolaides, K.H., Warsof, S.L., Fysh, W.J., Gamsu, H.R. and Kemp, J.R.: The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Amer. J. Obstetr. Gynecol. 150:769–774, 1984.Google Scholar
  257. Rodin, A.E. and Nichols, M.M.: Congestive heart failure in the fetus and during the first day of life. Texas Med. 72:44–48, 1975.Google Scholar
  258. Rodis, J.F., Hovick, T.J., Quinn, D.L., Rosengren, S.S. and Tattersall, P.: Human parvovirus infection in pregnancy. Obstet. Gynecol. 72:733–738, 1988.PubMedGoogle Scholar
  259. Rodis, J.F., Quinn, D.L., Gary, G.W., Anderson, L.J., Rosengren, S., Cartter, M.L., Campbell, W.A. and Vintzileos, A.M.: Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Amer. J. Obstet. Gynecol. 163:1168–1171, 1990.Google Scholar
  260. Rodis, J.F., Borgida, A.F., Wilson, M., Egan, J.F.X., Leo, M.V., Odibo, A.O. and Campbell, W.A.: Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of perinatal obstetricians. Amer. J. Obstet. Gynecol. 179:985–988, 1998.Google Scholar
  261. Rodriguez, M.M., Chaves, F., Romaguera, R.L., Ferrer, P.L., Guardia, C. de la and Bruce, J.H.: Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses. Pediatr. Devel. Pathol. 5:365–374, 2002.Google Scholar
  262. Rönisch, P. und Kleihauer, E.: Alpha-Thalassämie mit HbH und Bart’s in einer deutschen Familie. Klin. Wchschr. 45:1193–1200, 1967.Google Scholar
  263. Rogers, B.B.: Histopathologic variability of finding erythroid inclusions with intranuclear parvovirus B19 infection. Pediatr. Pathol. 12:883–889, 1992.PubMedGoogle Scholar
  264. Rogers, B.B., Mark, Y. and Oyer, C.E.: Diagnosis and incidence of fetal parvovirus infection in an autopsy series: I. Histology. Pediatr. Pathol. 13:371–379, 1993.PubMedGoogle Scholar
  265. Rogers, B.B., Rogers, Z.R. and Timmons, C.F.: Polymerase chain reaction amplification of archival material for parvovirus B19 in children with transient erythroblastopenia of childhood. Pediatr. Pathol. Lab. Med. 16471–478, 1996.Google Scholar
  266. Rogers, B.B., Bloom, S.L. and Buchanan, G.R.: Autosomal dominantly inherited Diamond-Blackfan anemia resulting in non-immune hydrops. Obstet. Gynecol. 89:805–807, 1997.PubMedGoogle Scholar
  267. Rubin, E.M. and Kan, Y.W.: A simple sensitive prenatal test for hydrops fetalis caused by α-thalassemia. Lancet i:75–77, 1985.Google Scholar
  268. Sacks, L.M., Polin, J.I. and Breckenridge, J.: Congenital chylothorax presenting as hydrops fetalis. A case report. J. Reprod. Med. 28:341–344, 1983.Google Scholar
  269. Sahakian, V., Weiner, C.P., Naides, S.J., Williamson, R.A. and Scharosch, L.L.: Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Amer. J. Obstet. Gynecol. 164:1090–1091, 1991.Google Scholar
  270. Saltzman, D.H., Frigoletto, F.D., Harlow, B.L., Barss, V.A. and Benacerraf, B.R.: Sonographic evaluation of hydrops fetalis. Obstet. Gynecol. 74:106–111, 1989.PubMedGoogle Scholar
  271. Samra, J.S., Obhrai, M.S. and Constantine, G.: Parvovirus infection in pregnancy. Obstet. Gynecol. 73:832–834, 1989.PubMedGoogle Scholar
  272. Santolaya, J., Alley, D., Jaffe, R. and Warsof, S.L.: Antenatal classification of hydrops fetalis. Obstet. Gynecol. 79:256–259, 1992.PubMedGoogle Scholar
  273. Scheib, J.S. and Waxman, J.: Congenital heart block in successive pregnancies: a case report and evaluation of risk with therapeutic consideration. Obstet. Gynecol. 73:481–484, 1989.PubMedGoogle Scholar
  274. Schumacher, B. and Moise, K.J.: Fetal transfusion for red blood cell alloimmunization. In pregnancy. Obstet. Gynecol. 88:137–150, 1996.Google Scholar
  275. Schwanitz, G., Zerris, K., Niesen, M., Haverkamp, F. and Schmid, G.: Hydrops fetalis as an indication for prenatal chromosome analysis with the example of the diagnosis of a duplication 15q11 and 17q25 due to familial translocation 15/17. Ann. Genet. 31:186–189, 1988.PubMedGoogle Scholar
  276. Schwartz, S.M., Visekul, C., Laxova, R., McPherson, E. and Gilbert, E.F.: Idiopathic hydrops fetalis report of 4 patients including 2 affected sibs. Amer. J. Med. Genet. 8:59–66, 1981.Google Scholar
  277. Schwarz, T.F., Roggendorf, M., Hottenträger, Deinhardt, B., Enders, G., Gloning, K.P., Schramm, T. and Hansmann, M.: Human parvovirus B19 infection in pregnancy. Lancet ii:566–567, 1988.Google Scholar
  278. Schwarz, T.F., Nerlich, A., Hottenträger, B., Jäger, G., Wiest, I., Kantimm, S., Roggendorf, H., Schultz, M., Gloning, K.P., Schramm, T., Holzgreve, W. and Roggendorf, M.: Parvovirus B19 infection of the fetus. Histology and in situ hybridization. Amer. J. Clin. Pathol. 95:121–126, 1991.Google Scholar
  279. Scott, J.R., Beer, A.E., Guy, L.R., Liesch, M. and Elbert, G.: Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding. Obstetr. Gynecol. 49:9–14, 1977.Google Scholar
  280. Seeds, J.W., Herbert, W.N.P., Bowles, W.A. and Cefalo, R.C.: Recurrent idiopathic fetal hydrops: results of prenatal therapy. Obstet. Gynecol. 64:30S–33S, 1984.PubMedGoogle Scholar
  281. Seeds, J.W., Bowes, W.A. and Chescheir, N.C.: Echogenic venous turbulence is a critical feature of successful intravascular transfusion. Obstetr. Gynecol. 73:488–490, 1989.Google Scholar
  282. Seifer, D.B., Ferguson, J.E., Behrens, C.M., Zemel, S., Stevenson, D.K. and Ross, J.: Nonimmune hydrops fetalis in association with hemangioma of the umbilical cord. Obstet. Gynecol. 66:283–286, 1985.PubMedGoogle Scholar
  283. Selm, M.V., Kanhai, H.H.H. and Gravenhorst, J.B.: Maternal hydrops syndrome: a review. Obstetr. Gynecol. Surv. 46:785–788, 1991.Google Scholar
  284. Seppälä, M., Aula, P., Rapola, J., Karjalainen, O., Huttunen, N.-P. and Ruoslahti, E.: Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of amniotic-fluid and maternal serum alpha-fetoprotein. Lancet i:123–125, 1976.Google Scholar
  285. Seward, J.F. and Zusman, J.: Hydrops fetalis associated with small-bowel volvulus. Lancet ii:52–53, 1978.Google Scholar
  286. Sexauer, C.L., Graham, H.L., Starling, K.A. and Fernbach, D.J.: A test for abnormal hemoglobins in umbilical cord blood. Amer. J. Dis. Childr. 130:805–806, 1976.Google Scholar
  287. Sheikh, A.U., Ernest, J.M. and O’Shea, M.: Long-term outcome in fetal hydrops from parvovirus B 19 infection. Amer. J. Obstet. Gynecol. 167:337–341, 1992.Google Scholar
  288. Shimokawa, H., Hara, K., Fukuda, A. and Nakano, H.: Idiopathic hydrops fetalis successfully treated in utero. Obstet. Gynecol. 71:984–986, 1988.PubMedGoogle Scholar
  289. Shiraishi, S., Kinukawa, N., Nakano, H. and Sueishi, K.: Immunohistochemical distribution of vascular endothelial growth factor in the human placenta associated with hydrops fetalis. Pediatr. Pathol. Lab. Med. 17:65–81, 1997.PubMedGoogle Scholar
  290. Silber, D.L. and Durnim, R.E.: Intrauterine atrial tachycardia. Associated with massive edema in a newborn. Amer. J. Dis. Childr. 117:722–726, 1969.Google Scholar
  291. Silver, M.M., Beverley, D.W., Valberg, L.S., Cutz, E., Phillips, M.J. and Shaheed, W.A.: Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies. Amer. J. Pathol. 128:538–554, 1989.Google Scholar
  292. Silverstein, A.J. and Kanbour, A.I.: Repetitive idiopathic fetal hydrops. Obstet. Gynecol. 57:18S–21S, 1981.PubMedGoogle Scholar
  293. Sklansky, M., Greenberg, M., Lucas, V. and Gruslin-Giroux, A.: Intrapericardial teratoma in a twin fetus: diagnosis and management. Obstet. Gynecol. 89:807–809, 1997.PubMedGoogle Scholar
  294. Skogerboe, K.J., West, S.F., Smith, C., Terashita, S.T., LeCrone, C.N., Detter, J.C. and Tait, J.F.: Screening for α-thalassemia. Correlation of hemoglobin H inclusion bodies with DNA-determined genotype. Arch. Pathol. Lab. Med. 116:1012–1018, 1992.PubMedGoogle Scholar
  295. Skopec, L.L. and Lakatua, D.J.: Non-immune fetal hydrops with hepatic hemangioendothelioma and Kasabach-Merritt syndrome: a case report. Pediatr. Pathol. 9:87–93, 1989.PubMedGoogle Scholar
  296. Slikke, J.W. v.d. and Balk, A.G.: Hydramnios with hydrops fetalis and disseminated fetal neuroblastoma. Obstet. Gynecol. 55:250–253, 1980.PubMedGoogle Scholar
  297. Smith, C.R., Chan, H.S.L. and DeSa, D.J.: Placental involvement in congenital neuroblastoma. J. Clin. Pathol. 34:785–789, 1981.PubMedGoogle Scholar
  298. Socol, M.L., Macgregor, S.N., Pielet, B.W., Tamura, R.K. and Sabbagha, R.E.: Percutaneous umbilical transfusion in severe rhesus isoimmunization: resolution of fetal hydrops. Amer. J. Obstetr. Gynecol. 157:1369–1375, 1987.Google Scholar
  299. Soothill, P.: Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection. Lancet 336:121–122, 1990.PubMedGoogle Scholar
  300. Srivastara, A. and Lu, L.: Replication of B19 parvovirus in highly enriched haematopoietic progenitor cells from normal human bone marrow. J. Virol. 62:3059–3063, 1988.Google Scholar
  301. Stedman, C.M., Quinlan, R.W., Huddleston, J.F., Cruz, A.C. and Kellner, K.R.: Rh sensitization after third-trimester fetal death. Obstetr. Gynecol. 71:461–463, 1988.Google Scholar
  302. Steinke, J., Gries, F.A. and Driscoll, S.G.: In vitro studies of insulin inactivation with reference to erythroblastosis fetalis. Blood 30:359–363, 1967.PubMedGoogle Scholar
  303. Stevens, D.C., Hilliard, J.K., Schreiner, R.L., Hurwitz, R.A., Murrell, R., Mirkin, L.D., Bonderman, P.W. and Nolen, P.A.: Supraventricular tachycardia with edema, ascites, and hydrops in fetal sheep. Amer. J. Obstet. Gynecol. 142:316–322, 1982.Google Scholar
  304. Stocker, J.T. and Singer, D.B.: Human parvovirus B19 infection, hydrops fetalis, and possibly myocarditis. Annotated bibliography. Pediatr. Pathol. 8:356–358, 1988.Google Scholar
  305. Strauss, L. and Driscoll, S.G.: Congenital neuroblastoma involving the placenta. Reports of two cases. Pediatrics 34:23–31, 1964.PubMedGoogle Scholar
  306. Suh, Y.K.: α-Thalassemia—differential diagnosis. J. Perinatol. 14:319–321, 1994.PubMedGoogle Scholar
  307. Swain, S. and Cameron, A.D.: Establishing the cause of nonimmune hydrops. Amer. J. Obstet. Gynecol. 176:951, 1997.Google Scholar
  308. Szulman, A.E.: The A, B and H blood-group antigens in human placenta. NEJM 286:1028–1031, 1972.PubMedGoogle Scholar
  309. Taylor, J.F.: Sensitization of Rh-negative daughters by their Rhpositive mothers. NEJM 276:547–551, 1967.PubMedGoogle Scholar
  310. Taylor, P.V., Scott, J.S., Gerbis, L.M., Esscher, E. and Scott, O.: Maternal antibodies against fetal cardiac antigens in congenital complete heart block. NEJM 315:667–672, 1986.PubMedGoogle Scholar
  311. Terheggen, H.G. und Kleihauer, E.: Die α-Thalassämie. Eine kasuistische Mitteilung. Z. Kinderh. 103:182–191, 1968.Google Scholar
  312. Thilaganathan, B., Salvesen, D.R., Abbas, A., Ireland, R.M. and Nicolaides, K.H.: Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies. Amer. J. Obstetr. Gynecol. 167:1292–1297, 1992.Google Scholar
  313. Thumasathit, B., Nondasuta, A., Silpisornkosol, S., Lousuebsakul, B., Unchalipongse, P. and Mangkornkanok, M.: Hydrops fetalis associated with Bart’s hemoglobin in northern Thailand. J. Pediatr. 73:132–138, 1968.PubMedGoogle Scholar
  314. Tolfvenstam, T., Papadogiannakis, N., Norbeck, O., Petersson, K. and Broliden, K.: Frequency of human parvovirus B19 infection in intrauterine death. Lancet 357:1494–1497, 2001. (see also Correspondence. Lancet 358:1180–1181, 2001).PubMedGoogle Scholar
  315. Treadwell, M.C., Sherer, D.M., Sacks, A.j., Ghezzi, F. and Romero, R.: Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism. Obstet. Gynecol. 87:838–840, 1996.PubMedGoogle Scholar
  316. Turski, D.M., Shahidi, N., Visekul, C. and Gilbert, E.: Nonimmunologic hydrops fetalis. Amer. J. Obstet. Gynecol. 131:586–587, 1978.Google Scholar
  317. Uno, Y., Taniguchi, A. and Tanaka, E.: Histochemical studies in Wolman’s disease—report of an autopsy case accompanied with a large amount of milky ascites. Acta Pathol. Jpn. 23:779–790, 1973.PubMedGoogle Scholar
  318. Van Kamp, I.L., Klumper, F.J.C.M., Oepkes, D., Meerman, R.H., Scherjon, S.A., Vandenbussche, F.P.H.A. and Kanhai, H.H.H.: Complications of intrauterine intravascular transfusion for fetal anemia due to re-cell alloimmunization. Amer. J. Obstet. Gynecol. 192:171–177, 2005.Google Scholar
  319. Vaughan, J.I., Manning, M., Warwick, R.M., Letsky, E.A., Murray, N.A. and Roberts, I.A.G.: Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. NEJM 338:798–803, 1998.PubMedGoogle Scholar
  320. Vedvick, T.S., Wheeler, S.A. and Koenig, H.M.: Heterogeneity of fetal hemoglobin in severe α-thalassemia. Biol. Neonate 36:181–184, 1979.PubMedGoogle Scholar
  321. Veille, J.C., Sunderland, C. and Bennett, R.M.: Complete heart block in a fetus associated with maternal Sjögren’s syndrome. Amer. J. Obstet. Gynecol. 151:660–661, 1985.Google Scholar
  322. Verger, P., Martin, C., Dubecq, J.-P., Kermarec, Y. et Lomazzi, R.: Étude pathologique et therapeutique de l’anasarque foeto-placentaire. Arch. Franc. Pediatr. 20:417–436, 1963.Google Scholar
  323. Vetter, V.L. and Rashkind, W.J.: Congenital complete heart block and connective-tissue disease. NEJM 309:236–238, 1983.PubMedGoogle Scholar
  324. Veyer, I.B.v.d. and Moise, K.J.: Fetal RhD typing by polymerase chain reaction in pregnancies complicated by rhesus alloimmunization. Obstet. Gynecol. 88:1061–1067, 1996.Google Scholar
  325. Veyer, I.B.v.d., Subramanian, S.B., Hudson, K.M., Werch, J., Moise, K.J. and Hughes, M.R.: Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet. Gynecol. 87:419–422, 1996.Google Scholar
  326. Vidyasagar, D. and Haworth, J.C.: Placental dimensions, cell size, and cell number in erythroblastosis fetalis. Amer. J. Obstetr. Gynecol. 115:267–270, 1973.Google Scholar
  327. Villaespesa, A.R., Mier, M.P.S., Ferrer, P.L., Baleriola, I.A. and Gonzalez, J.I.R.: Nonimmunologic hydrops fetalis: An etiopathogenetic approach through the postmortem study of 59 patients. Amer. J. Med. Genet. 35:274–279, 1990.Google Scholar
  328. Ville, Y., Proudler, A., Abbas, A. and Nicolaides, K.: Atrial natriuretic factor concentration in normal, growth-retarded, anemic, and hydropic fetuses. Amer. J. Obstet. Gynecol. 171:777–783, 1994a.Google Scholar
  329. Ville, Y., Proudler, A., Kuhn, P. and Nicolaides, K.: Aldosterone concentration in normal, growth-retarded, anemic, and hydropic fetuses. Obstet. Gynecol. 84:511–514, 1994b.PubMedGoogle Scholar
  330. Vintzileos, A.M., Campbell, W.A., Soberman, S.M. and Nochimson, D.J.: Fetal atrial flutter and X-linked dominant vitamin D-resistant rickets. Obstet. Gynecol. 65:39S–44S, 1985.PubMedGoogle Scholar
  331. Vogel, H., Kornman, M., Ledet, S.C., Rajagopalan, L., Taber, L. and McClain, K.: Congenital parvovirus infection. Pediatr. Pathol. Lab. Med. 17:903–912, 1997.PubMedGoogle Scholar
  332. Warren, R.C., Butler, J., Morsman, J.M., Mckenzie, C. and Rodeck, C.H.: Does chorionic villus sampling cause fetomaternal hemorrhage? Lancet i:691, 1985.Google Scholar
  333. Watson, J. and Campbell, S.: Antenatal evaluation and management in nonimmune hydrops fetalis. Obstet. Gynecol. 67:589–593, 1986.PubMedGoogle Scholar
  334. Watson, W.J. and Fiegen, M.M.: Fetal thyrotoxicosis associated with nonimmune hydrops. Amer. J. Obstet. Gynecol. 172:1039–1040, 1995.Google Scholar
  335. Weiland, H.T., Vermey-Keers, C., Salimans, M.M.M., Fleuren, G.J., Verwey, R.A. and Anderson, M.J.: Parvovirus B19 associated with fetal abnormality. Lancet i:682–683, 1987.Google Scholar
  336. Weiner, C.P and Thompson, I.B.: Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Amer. J. Obstet. Gynecol. 158:570–573, 1988.Google Scholar
  337. Weiner, C., Varner, M., Pringle, K., Hein, H., Williamson, R. and Smith, W.L.: Antenatal diagnosis and palliative treatment of nonimmune hydrops fetalis secondary to extralobar sequestration. Obstet. Gynecol. 68:275–280, 1986.PubMedGoogle Scholar
  338. Weiner, C.P., Sipes, S.L. and Wenstrom, K.: The effect of fetal age upon normal fetal laboratory values and venous pressure. Obstetr. Gynecol. 79:713–718, 1992.Google Scholar
  339. Wentworth, P.: The placenta in cases of hemolytic disease. Amer. J. Obstetr. Gynecol. 98:283–289, 1967.Google Scholar
  340. Westgren, M., Eastman, W.N., Ghandourah, S. and Woodhouse, N.: Intrauterine hypercalcaemia and non-immune hydrops fetalis—relationship to the Williams syndrome. Prenatal Diagnosis 8:333–337, 1988.PubMedGoogle Scholar
  341. Whitney, J.B. and Popp, R.A.: Thalassemia. Alpha-thalassemia in laboratory mice. Amer. J. Pathol. 116:523–525, 1984.Google Scholar
  342. Wiener, A.S., Wexler, I.B. and Schutta, E.J.: A pair of male fraternal twins with contrasting manifestations of Rh hemolytic disease. Acta Genet. Med. Gemell. 11:17–28, 1962.Google Scholar
  343. Wiggins, J.W., Bowes, W., Clewell, W., Manco-Johnson, M., Manchester, D., Johnson, R., Appareti, K. and Wolfe, R.R.: Echocardiographic diagnosis and intravenous digoxin management of fetal tachyarrhythmias and congestive heart failure. Amer. J. Dis. Childr. 140:202–204, 1986.Google Scholar
  344. Williamson, R., Eskdale, J., Coleman, D.V., Niazi, M., Loeffler, F.E. and Modell, B.M.: Direct gene analysis of chorionic villi: a possible technique for first-trimester antenatal diagnosis of haemoglobinopathies. Lancet ii:1125–1127, 1981.Google Scholar
  345. Windebank, K.P., Bridges, N.A., Ostman-Smith, I. and Stevens, J.E.: Hydrops fetalis due to abnormal lymphatics. Arch. Dis. Childh. 62:198–200, 1987.PubMedGoogle Scholar
  346. Wood, W.G., Bunch, C., Kelley, S., Gunn, Y. and Breckon, G.: Control of haemoglobin switching by a developmental clock? Nature 313:320–323, 1985.PubMedGoogle Scholar
  347. Yamakawa, Y., Oka, H., Hori, S., Arai, T. and Izumi, R.: Detection of human parvovirus B19 DNA by nested polymerase chain reaction. Obstet. Gynecol. 86:126–129, 1995.PubMedGoogle Scholar
  348. Younis, J.S. and Granat, M.: Insufficient transplacental digoxin transfer in severe hydrops fetalis. Amer. J. Obstet. Gynecol. 157:1268–1269, 1987.Google Scholar
  349. Zeng, Y.-T. and Hunag, S.-Z.: α-Globin gene organisation and prenatal diagnosis of α-thalassemia in Chinese. Lancet i:304–307, 1985.Google Scholar
  350. Zipursky, A. and Israels, L.G.: The pathogenesis and prevention of Rh immunization. Canad. Med. Assoc. J. 97:1245–1257, 1967.PubMedGoogle Scholar
  351. Zwi, L.J. and Becroft, D.M.O.: Intrauterine aplastic anemia and fetal hydrops: a case report. Pediatr. Pathol. 5:199–205, 1986.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Personalised recommendations